General
Glaxo Smith Kline (BIOC.CA) - Board of Directors Decisions
Published at 13 August 2026 at 11:14Glaxo Smith KlineRelated stock:Glaxo Smith Kline stockAll Glaxo Smith Kline disclosures
Disclosure summary
Company Name : Glaxo Smith Kline
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Based on the decisions of the company's Board of Directors at its meeting held on 12/08/2026, EGX decided to resume trading in the company's shares starting from 13/08/2026 trading session at 12:55 PM.
Board of Directors' Decisions in Arabic & English (937 KB)
The BoD Report (3,369 KB)
Release from the Company (306 KB)
ISIN Code : EGS38171C012
Reuters Code : BIOC.CA
Content :
Based on the decisions of the company's Board of Directors at its meeting held on 12/08/2026, EGX decided to resume trading in the company's shares starting from 13/08/2026 trading session at 12:55 PM.
Board of Directors' Decisions in Arabic & English (937 KB)
The BoD Report (3,369 KB)
Release from the Company (306 KB)